Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Catheter-directed Venous Thrombolysis (CaVenT) in Acute Iliofemoral Vein Thrombosis
2005-004486-42Phase 4Active
- Sponsor
- South-Eastern Norway Regional Health Authority
- Start
- Nov 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of tissue-plasminogen activator in deep vein thrombosis (DVT) (2 arms), sponsored by South-Eastern Norway Regional Health Authority. Primary endpoints: Venous patency at 6 months, Post-thrombotic syndrome at 2 years and 1 more. Started Nov 2005; status: active.
02
Drugs
tissue-plasminogen activator
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on 2005-004486-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004486-42.